Based on the data analysis, visudyne.com underwent 0 accessibility tests in the 0 days that followed June 17, 2026. Visudyne.com was noted as either unavailable or facing other issues during all checks completed as of June 17, 2026. As of June 17, 2026, there were no periods of inactivity for visudyne.com throughout all checks. As of June 17, 2026, the replies that were received indicated that there were no reported errors in the responses. In 0 seconds, visudyne.com responded on June 17, 2026, compared with its average of 0.000 seconds.
For AMD patients with predominantly classic subfoveal choroidal neovascularization | VISUDYNE
Description
VISUDYNE® (verteporfin for injection) therapy is a photoenhancer indicated for the treatment of patients with predominantly classic subfoveal choroidal neovascularization (CNV) due to age-related macular degeneration, pathologic myopia or presumed ocular histoplasmosis.
Main Topic
WHEN PERSISTENT RETINAL FLUID HOLDS THEM BACK… take action with visudyne ®